This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
56R0 株式概要
Through its subsidiary, NanoVibronix Ltd., focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally.
NanoVibronix, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$5.82 |
| 52週高値 | US$24.00 |
| 52週安値 | US$4.18 |
| ベータ | 0.91 |
| 11ヶ月の変化 | 0% |
| 3ヶ月変化 | 1.39% |
| 1年変化 | -54.13% |
| 33年間の変化 | n/a |
| 5年間の変化 | n/a |
| IPOからの変化 | -85.42% |
最新ニュース
Recent updates
株主還元
| 56R0 | DE Medical Equipment | DE 市場 | |
|---|---|---|---|
| 7D | 0% | -2.7% | -1.8% |
| 1Y | -54.1% | -2.7% | 13.6% |
業界別リターン: 56R0 underperformed the German Medical Equipment industry which returned -2.5% over the past year.
リターン対市場: 56R0 underperformed the German Market which returned 5.9% over the past year.
価格変動
| 56R0 volatility | |
|---|---|
| 56R0 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
安定した株価: 56R0 has not had significant price volatility in the past 3 months.
時間の経過による変動: Insufficient data to determine 56R0's volatility change over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2003 | 12 | Brian Murphy | www.nanovibronix.com |
NanoVibronix, Inc. 基礎のまとめ
| 56R0 基礎統計学 | |
|---|---|
| 時価総額 | €5.52m |
| 収益（TTM） | -€4.94m |
| 売上高(TTM) | €682.29k |
8.1x
P/Sレシオ-1.1x
PER（株価収益率56R0 は割高か？
公正価値と評価分析を参照収益と収入
| 56R0 損益計算書（TTM） | |
|---|---|
| 収益 | US$752.00k |
| 売上原価 | US$585.00k |
| 売上総利益 | US$167.00k |
| その他の費用 | US$5.62m |
| 収益 | -US$5.45m |
直近の収益報告
Dec 31, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -3.28 |
| グロス・マージン | 22.21% |
| 純利益率 | -724.47% |
| 有利子負債／自己資本比率 | 0% |
56R0 の長期的なパフォーマンスは？
過去の実績と比較を見る